TOMASSINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 4.423
AS - Asia 2.601
EU - Europa 1.475
SA - Sud America 440
AF - Africa 60
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.017
Nazione #
US - Stati Uniti d'America 4.331
SG - Singapore 1.460
CN - Cina 463
RU - Federazione Russa 355
BR - Brasile 353
IT - Italia 317
VN - Vietnam 292
IE - Irlanda 278
GB - Regno Unito 107
DE - Germania 102
HK - Hong Kong 88
SE - Svezia 85
IN - India 73
BD - Bangladesh 49
CA - Canada 47
FI - Finlandia 37
JP - Giappone 33
AR - Argentina 32
MX - Messico 30
ES - Italia 25
AT - Austria 24
FR - Francia 24
KR - Corea 21
PL - Polonia 21
UA - Ucraina 21
IQ - Iraq 20
TR - Turchia 20
ZA - Sudafrica 20
AU - Australia 13
NL - Olanda 13
PK - Pakistan 13
EC - Ecuador 12
VE - Venezuela 10
BE - Belgio 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
ID - Indonesia 9
IR - Iran 9
LT - Lituania 9
PY - Paraguay 9
CL - Cile 8
MA - Marocco 8
RO - Romania 7
UZ - Uzbekistan 7
CO - Colombia 6
EG - Egitto 6
KE - Kenya 6
PA - Panama 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DZ - Algeria 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
IL - Israele 3
OM - Oman 3
UY - Uruguay 3
AZ - Azerbaigian 2
EU - Europa 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
KH - Cambogia 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MV - Maldive 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
Totale 9.010
Città #
Singapore 1.149
Dallas 938
San Jose 655
Ashburn 355
Chandler 286
Dublin 274
Santa Clara 174
Beijing 143
Council Bluffs 111
Los Angeles 103
The Dalles 100
Ho Chi Minh City 86
Hong Kong 85
Jacksonville 84
Princeton 82
New York 57
St Louis 57
Hanoi 56
Hefei 51
Tongling 48
Buffalo 47
Munich 44
Orem 44
Altamura 41
São Paulo 39
Moscow 34
Dong Ket 33
Tokyo 32
Redondo Beach 31
Rome 30
Nuremberg 29
Wilmington 29
London 24
Chennai 23
Pescara 22
Seoul 21
Washington 21
Denver 20
Chicago 19
Seattle 19
Brooklyn 18
Chieti 18
Montreal 18
Warsaw 18
Boston 17
Haiphong 17
Houston 17
Mexico City 16
Ann Arbor 15
Atlanta 15
Da Nang 15
Helsinki 15
Milan 15
Mumbai 14
Romola 14
Stockholm 14
Teramo 14
Johannesburg 13
Lappeenranta 13
Phoenix 13
Falls Church 12
Boardman 11
Frankfurt am Main 11
Camerino 10
Brussels 9
Campinas 9
Manchester 9
New Delhi 9
Rio de Janeiro 9
Toronto 9
Baghdad 8
Fairfield 8
Southend 8
Tehran 8
Vienna 8
Biên Hòa 7
Castignano 7
Istanbul 7
Poplar 7
Saint Petersburg 7
Sydney 7
Tashkent 7
Turku 7
Woodbridge 7
Cardiff 6
Dhaka 6
Düsseldorf 6
Nanchang 6
Naples 6
Norwalk 6
Porto Alegre 6
San Francisco 6
Santander 6
Shanghai 6
Amsterdam 5
Asunción 5
Belo Horizonte 5
Brasília 5
Cairo 5
Charlotte 5
Totale 6.096
Nome #
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 162
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 159
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 153
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 144
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 141
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 141
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 140
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 138
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 135
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 133
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 131
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 129
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 128
Brain morphometry in Multiple Sclerosis 127
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 120
Modelling the natural history of primary progressive multiple sclerosis 120
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 119
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 118
Tractography in the presence of multiple sclerosis lesions 118
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 117
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 115
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 113
Neuroplasticity and motor rehabilitation in multiple sclerosis 111
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 111
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 111
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 109
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 108
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 107
Age-related changes in grey and white matter structure throughout adulthood 106
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 106
Neurological update: MOG antibody disease 104
Oral contraceptives combined with interferon b in multiple sclerosis 104
Lessons from immunotherapies in multiple sclerosis 99
How common is truly benign MS in a UK population? 98
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 96
Medical education and MS: getting the training right 96
Predicting the profile of increasing disability in multiple sclerosis 96
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 96
Informing MS patients on treatment options: a consensus on the process of consent taking 94
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 93
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 91
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 90
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 90
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 90
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 89
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 89
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 88
Site-specific clinical disease onset in multiple sclerosis 87
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 86
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 86
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 86
Alexithymia in multiple sclerosis: relationship with fatigue and depression 85
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 84
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 84
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 83
Model-free characterization of brain functional networks for motor sequence learning using fMRI 83
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 83
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 82
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 81
Similarities and differences between multiple sclerosis and type 1 diabetes 81
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 80
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 80
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 79
Changes in brain perfusion with training-related visuomotor improvement in MS 79
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 78
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 78
Relating brain damage to brain plasticity in patients with multiple sclerosis 77
Neuroplasticity and functional recovery in multiple sclerosis 77
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 77
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 77
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 77
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 76
Exploring the contribution of gray matter microstructure to R1 contrast via multi-compartment diffusion modelling in the healthy brain 75
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 75
Diagnosis and management of multiple sclerosis: MRI in clinical practice 75
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 74
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 72
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 70
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 70
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 70
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 69
Structural and functional bases for individual differences in motor learning 69
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 69
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 68
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 65
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 65
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 64
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 62
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 62
Contemporary study of multiple sclerosis disability in South East Wales 62
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 61
Multiple sclerosis lesions: insights from imaging techniques 61
Sex hormones, brain damage and clinical course of Multiple Sclerosis 60
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 60
Preservation of motor skill learning in patients with multiple sclerosis 59
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 56
Transverse myelitis in children and adults 53
Sex hormones: a role in the control of multiple sclerosis? 50
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 46
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 44
Totale 9.185
Categoria #
all - tutte 40.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20252.205 120 544 421 52 47 58 76 82 192 147 161 305
2025/20265.057 334 224 1.141 528 345 187 596 320 529 438 295 120
Totale 9.438